Concepedia

Publication | Open Access

Once-weekly TransCon CNP (navepegritide) in children with achondroplasia (ACcomplisH): a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-escalation trial

18

Citations

15

References

2023

Year

Abstract

Ascendis Pharma, A/S.

References

YearCitations

Page 1